Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73566942)
Watch
English
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000
scientific article published on 01 January 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
title
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
main subject
chronic renal insufficiency
1 reference
based on heuristic
inferred from title
publication date
1 January 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
published in
American Journal of Kidney Diseases
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
volume
37
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
page(s)
S182-238
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
issue
1 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
cites work
Anemia of end-stage renal disease (ESRD).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved Physical Performance after Treatment of Renal Anemia with Recombinant Human Erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Working capacity is increased following recombinant human erythropoietin treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin: implications for nephrology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of recombinant erythropoietin on sexual function in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Erythropoietin on Sexual Potency In Chronic Haemodialysis Patients: A Preliminary Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anemia of uremia is associated with reduced in vitro cytokine secretion: immunopotentiating activity of red blood cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contributing factors to the inhibition of phagocytosis in hemodialyzed patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of Iron Deficiency Anemia in Patients on Maintenance Dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of secondary hyperparathyroidism in the anemia of chronic renal failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aluminum-induced anemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoiesis in patients with renal failure undergoing chronic dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The future of r-HuEPO.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence-based recommendations for the clinical use of recombinant human erythropoietin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stability of blood in commonly used anticoagulants. Use of refrigerated blood for quality control of the Coulter Counter Model S
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Spurious elevation of the electronically determined mean corpuscular volume and hematocrit caused by hyperglycemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of red cell shape on the measurement of red cell volume. A proposed method for the comparative assessment of this effect among various haematology analysers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biologic variation of common hematologic laboratory quantities in the elderly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of the anemia associated with chronic renal insufficiency
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
THE DIAGNOSIS OF IRON DEFICIENCY ANEMIA
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ferritin in serum. Clinical and biochemical implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of functional iron deficiency during erythropoietin treatment: a new approach
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical parameters in chronic renal failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anemia of chronic disease: a misnomer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathogenesis and treatment of the anemia of chronic disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Balance between pro-inflammatory cytokines and their specific inhibitors in patients on dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Uremic cardiomyopathy: an inadequate left ventricular hypertrophy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of left ventricular hypertrophy on survival in end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
National Cooperative rHu Erythropoietin Study in patients with chronic renal failure--an interim report. The National Cooperative rHu Erythropoietin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pervasive failed rehabilitation in center-based maintenance hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin in chronic renal failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Haemoglobin--is more better?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and blood rheologic stability in erythropoietin-treated predialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of the anemia of progressive renal failure with recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Normalization of hematocrit with recombinant human erythropoietin in chronic hemodialysis patients does not fully improve their exercise tolerance abilities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Normalizing hematocrit in dialysis patients improves brain function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Premature birth and maternal prenatal anemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hemorheology of the cerebral circulation in stroke
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinant of the optimal hematocrit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Absence of anemia in maintenance hemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous ferric saccharate as an iron supplement in dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled study of iron supplementation in patients treated with erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How to get the best out of r-HuEPO
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron metabolism under rEPO therapy in patients on maintenance hemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intra-dialytic oral iron therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron balance in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron Absorption in Chronic Renal Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of intravenous injection of iron saccharate in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: a prospective analysis and comparison of two agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How to diagnose and correct iron deficiency during r-huEPO therapy--a consensus report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic reactions to intravenous iron therapy in patients receiving angiotensin converting enzyme inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serious adverse reactions after intravenous ferric gluconate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous Iron Dextran in Clinical Medicine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety of intravenous iron dextran in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron overload and mobilization in long-term hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron and infection: new developments and their implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron withholding: a defense against infection and neoplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Variations of recombinant human erythropoietin application in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intraperitoneal erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Experience with low dose intravenous and subcutaneous administration of recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differences in intravenous and subcutaneous application of recombinant human erythropoietin: a multicenter trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous erythropoietin and peritoneal dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Must erythropoietin be injected by the subcutaneous route for every hemodialyzed patient?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin in anemic patients on maintenance hemodialysis: comparison between intravenous and subcutaneous administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of dose requirement, serum erythropoietin and blood pressure following intravenous and subcutaneous erythropoietin treatment of dialysis patients. IV and SC erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and Dose Response after Intravenous and Subcutaneous Administration of Recombinant Erythropoietin in Patients on Regular Haemodialysis Treatment or Continuous Ambulatory Peritoneal Dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pharmacodynamic model of erythropoietin therapy for uremic anemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of recombinant human erythropoietin treatment on renal anemia and body growth of children with end-stage renal disease. The European Multicenter Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum erythropoietin levels after renal transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dynamics of erythropoiesis following renal transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
R-HuEPO hyporesponsiveness--who and why?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
R-HuEPO hyporesponsiveness--who and why?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin, aluminium, and anaemia in patients on haemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin for Anemia of Renal Failure in Sickle Cell Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin in anemia of renal failure in sickle cell disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of recombinant erythropoietin in thalassemic patients on dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Folic acid supplementation improves erythropoietin response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of erythropoietin in patients with myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors limiting the erythropoietin response in rapidly growing infants with congenital nephrosis on a peritoneal dialysis regimen after nephrectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac hemolysis and anemia refractory to erythropoietin: on anemia in dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: about two cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival as an index of adequacy of dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Practice strategies for elective red blood cell transfusion. American College of Physicians
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epoetin alfa in anaemic children or adolescents on regular dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to erythropoietin in anaemic haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin receptor mRNA expression in human endothelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of erythropoietin treatment on arteriovenous haemodialysis fistula/graft: A prospective study with colour flow doppler ultrasonography
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Side effects during recombinant human erythropoietin therapy in 2,000 ESRD patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human erythropoietin: 18 months' experience in hemodialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of the Anemia of Hemodialysis Patients with Recombinant Human Erythropoietin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autoregulatory capacity and the effect of isovolemic hemodilution on local cerebral blood flow
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of hemodilution on cerebral hemodynamics and oxygen metabolism.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence for high risk of cerebral hemorrhage in chronic dialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iron status in patients receiving erythropoietin for dialysis-associated anemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical consequences of acquired transfusional iron overload in adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of the erythropoietin receptor on a human myeloma cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970008-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0272-6386(01)70008-X
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
PubMed ID
11229970
1 reference
stated in
Europe PubMed Central
PubMed ID
11229970
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229970%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
